2-Bromohexadecanoic acid - CAS 18263-25-7
Catalog: |
BB014011 |
Product Name: |
2-Bromohexadecanoic acid |
CAS: |
18263-25-7 |
Synonyms: |
2-bromohexadecanoic acid |
IUPAC Name: | 2-bromohexadecanoic acid |
Description: | 2-Bromohexadecanoic acid (CAS# 18263-25-7) is used in preparation of substituted purines and their analogs for inhibiting the expression of a pattern recognition receptor. |
Molecular Weight: | 335.32 |
Molecular Formula: | C16H31BrO2 |
Canonical SMILES: | CCCCCCCCCCCCCCC(C(=O)O)Br |
InChI: | InChI=1S/C16H31BrO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(17)16(18)19/h15H,2-14H2,1H3,(H,18,19) |
InChI Key: | DPRAYRYQQAXQPE-UHFFFAOYSA-N |
Boiling Point: | 403.4 °C at 760 mmHg |
Purity: | 98 % |
Density: | 1.114 g/cm3 |
Appearance: | White crystalline powder |
MDL: | MFCD00004215 |
LogP: | 5.92570 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113215162-A | Reduction of Al-induced Abeta1-42Expression level interfering RNA and application thereof | 20210602 |
CN-112479971-A | 2-bromo-1- (7-nitroindoline) hexadecanone compound and preparation method and application thereof | 20201209 |
CN-111789833-A | Application of 2-bromopalmitic acid in preparation of medicine for preventing and treating bone loss related diseases | 20200831 |
KR-102174457-B1 | Compounds for quantum dot ligand comprising a (meth)acrylate structure having carboxyl group, quantum dot particles comprising quantum dot ligands formed by the compounds, and composition comprising the quantum dot particles, and preparation method of the compounds | 20200603 |
KR-102207330-B1 | Compounds for quantum dot ligand comprising a (meth)acrylate structure having carboxyl group, quantum dot particles comprising quantum dot ligands formed by the compounds, and composition comprising the quantum dot particles, and preparation method of the compounds | 20200603 |
PMID | Publication Date | Title | Journal |
30076181 | 20190101 | 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia | Haematologica |
23001822 | 20121201 | Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity | Molecular & cellular proteomics : MCP |
22753418 | 20120817 | Amino-terminal cysteine residues differentially influence RGS4 protein plasma membrane targeting, intracellular trafficking, and function | The Journal of biological chemistry |
22562470 | 20120801 | Plasma membrane localization is required for RasA-mediated polarized morphogenesis and virulence of Aspergillus fumigatus | Eukaryotic cell |
22728137 | 20120730 | RING finger palmitoylation of the endoplasmic reticulum Gp78 E3 ubiquitin ligase | FEBS letters |
Complexity: | 207 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 334.15074 |
Formal Charge: | 0 |
Heavy Atom Count: | 19 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 334.15074 |
Rotatable Bond Count: | 14 |
Topological Polar Surface Area: | 37.3 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 7.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS